Marketing is an area of great change for pharmaceutical companies based on evolutions in markets, customers, and marketing channels. To help your brands stay ahead of this evolving landscape, TGaS provides brand-level benchmarks that provide a comparative analysis for insight into key imperatives such as:

Where am I under-investing compared to similar brands?

What channels are comparative brands shifting their investments to?

How is budget spent between HCP and patient audiences?

Comparable Brands

Using our database of budgets from more than 400 brands, we choose a subset of comparable brands based on size of patient population, lifecycle stage, and other key characteristics.

Case Study

Background – A portfolio of endocrinology brands was asked by senior leadership to reduce its upcoming fiscal spend by over $40 million.

TGaS Engagement – Leveraging its PharmaStance^® benchmarking methodology, TGaS compared its spend, engagement and overall performance to high prevalence mature brands.

Insights – Before budget reductions, the portfolio was already invested 25% less than other similar brands.

Results – While budget reduction was still required, the portfolio was able to maintain an additional $20 million in investment based upon the benchmark outcomes.